{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,3]],"date-time":"2026-11-03T21:17:01Z","timestamp":1793740621253,"version":"4.6.1"},"reference-count":36,"publisher":"Elsevier BV","issue":"9","license":[{"start":{"date-parts":[[2019,9,1]],"date-time":"2019-09-01T00:00:00Z","timestamp":1567296000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2019,9,1]],"date-time":"2019-09-01T00:00:00Z","timestamp":1567296000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","jhltonline.org","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["The Journal of Heart and Lung Transplantation"],"published-print":{"date-parts":[[2019,9]]},"DOI":"10.1016\/j.healun.2019.05.007","type":"journal-article","created":{"date-parts":[[2019,5,24]],"date-time":"2019-05-24T03:05:59Z","timestamp":1558667159000},"page":"930-938","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":31,"title":["Prognostic value of vasoactive-inotropic score following continuous flow left ventricular assist device implantation"],"prefix":"10.1016","volume":"38","author":[{"ORCID":"https:\/\/orcid.org\/0000-0001-8286-5355","authenticated-orcid":false,"given":"Jiho","family":"Han","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Alberto","family":"Pinsino","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Joseph","family":"Sanchez","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hiroo","family":"Takayama","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"A. Reshad","family":"Garan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Veli K.","family":"Topkara","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yoshifumi","family":"Naka","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ryan T.","family":"Demmer","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Paul A.","family":"Kurlansky","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Paolo C.","family":"Colombo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Koji","family":"Takeda","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Melana","family":"Yuzefpolskaya","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.healun.2019.05.007_bib0001","doi-asserted-by":"crossref","first-page":"2241","DOI":"10.1056\/NEJMoa0909938","article-title":"Advanced heart failure treated with continuous-flow left ventricular assist device","volume":"361","author":"Slaughter","year":"2009","journal-title":"N Engl J Med"},{"key":"10.1016\/j.healun.2019.05.007_bib0002","doi-asserted-by":"crossref","DOI":"10.1136\/openhrt-2014-000109","article-title":"Trends in left ventricular assist device use and outcomes among Medicare beneficiaries, 2004-2011","volume":"1","author":"Lampropulos","year":"2014","journal-title":"Open Heart"},{"key":"10.1016\/j.healun.2019.05.007_bib0003","doi-asserted-by":"crossref","first-page":"1316","DOI":"10.1016\/j.jtcvs.2009.11.020","article-title":"Right ventricular failure in patients with the HeartMate II continuous-flow left ventricular assist device: incidence, risk factors, and effect on outcomes","volume":"139","author":"Kormos","year":"2010","journal-title":"J Thorac Cardiovasc Surg"},{"key":"10.1016\/j.healun.2019.05.007_bib0004","doi-asserted-by":"crossref","first-page":"186","DOI":"10.1016\/j.jtcvs.2013.01.044","article-title":"Temporary right ventricular mechanical circulatory support for the management of right ventricular failure in critically ill patients","volume":"146","author":"Aissaoui","year":"2013","journal-title":"J Thorac Cardiovasc Surg"},{"key":"10.1016\/j.healun.2019.05.007_bib0005","doi-asserted-by":"crossref","first-page":"885","DOI":"10.1056\/NEJMoa067758","article-title":"Use of a continuous-flow device in patients awaiting heart transplantation","volume":"357","author":"Miller","year":"2007","journal-title":"N Engl J Med"},{"key":"10.1016\/j.healun.2019.05.007_bib0006","doi-asserted-by":"crossref","first-page":"S106","DOI":"10.1016\/j.cardfail.2018.07.399","article-title":"Preoperative MEDL XI is not associated with mortality after LVAD","volume":"24","author":"Khayata","year":"2018","journal-title":"J Card Fail"},{"key":"10.1016\/j.healun.2019.05.007_bib0007","doi-asserted-by":"crossref","first-page":"251","DOI":"10.1097\/MAT.0000000000000494","article-title":"Low accuracy of the HeartMate Risk Score for Predicting Mortality Using the INTERMACS Registry Data","volume":"63","author":"Kanwar","year":"2017","journal-title":"ASAIO J"},{"key":"10.1016\/j.healun.2019.05.007_bib0008","doi-asserted-by":"crossref","first-page":"16814","DOI":"10.1038\/srep16814","article-title":"Circulating microbial RNA and health","volume":"5","author":"Leung","year":"2015","journal-title":"Sci Rep"},{"key":"10.1016\/j.healun.2019.05.007_bib0009","doi-asserted-by":"crossref","first-page":"841","DOI":"10.1136\/heartjnl-2015-308826","article-title":"Trimethylamine N-oxide and prognosis in acute heart failure","volume":"102","author":"Suzuki","year":"2016","journal-title":"Heart"},{"key":"10.1016\/j.healun.2019.05.007_bib0010","doi-asserted-by":"crossref","first-page":"91","DOI":"10.1016\/j.cardfail.2014.11.006","article-title":"Intestinal microbiota-dependent phosphatidylcholine metabolites, diastolic dysfunction, and adverse clinical outcomes in chronic systolic heart failure","volume":"21","author":"Tang","year":"2015","journal-title":"J Card Fail"},{"key":"10.1016\/j.healun.2019.05.007_bib0011","doi-asserted-by":"crossref","first-page":"717","DOI":"10.1111\/joim.12328","article-title":"Microbiota-dependent metabolite trimethylamine-N-oxide is associated with disease severity and survival of patients with chronic heart failure","volume":"277","author":"Tr\u00f8seid","year":"2015","journal-title":"J Intern Med"},{"key":"10.1016\/j.healun.2019.05.007_bib0012","doi-asserted-by":"crossref","first-page":"973","DOI":"10.1016\/j.cardfail.2015.09.017","article-title":"Intersections Between microbiome and heart failure: revisiting the gut hypothesis","volume":"21","author":"Nagatomo","year":"2015","journal-title":"J Card Fail"},{"key":"10.1016\/j.healun.2019.05.007_bib0013","doi-asserted-by":"crossref","first-page":"1908","DOI":"10.1016\/j.jacc.2014.02.617","article-title":"Prognostic value of elevated levels of intestinal microbe-generated metabolite trimethylamine-N-oxide in patients with heart failure: refining the gut hypothesis","volume":"64","author":"Tang","year":"2014","journal-title":"J Am Coll Cardiol"},{"key":"10.1016\/j.healun.2019.05.007_bib0014","doi-asserted-by":"crossref","first-page":"2948","DOI":"10.1093\/eurheartj\/ehx342","article-title":"Gut microbe-generated metabolite trimethylamine-N-oxide as cardiovascular risk biomarker: a systematic review and dose-response meta-analysis","volume":"38","author":"Schiattarella","year":"2017","journal-title":"Eur Heart J"},{"key":"10.1016\/j.healun.2019.05.007_bib0015","doi-asserted-by":"crossref","DOI":"10.1161\/JAHA.115.002767","article-title":"Trimethylamine N-oxide promotes vascular inflammation through signaling of mitogen-activated protein kinase and nuclear factor-\u03baB","volume":"5","author":"Seldin","year":"2016","journal-title":"J Am Heart Assoc"},{"key":"10.1016\/j.healun.2019.05.007_bib0016","doi-asserted-by":"crossref","first-page":"2226","DOI":"10.1161\/01.CIR.92.8.2226","article-title":"Postoperative course and hemodynamic profile after the arterial switch operation in neonates and infants. A comparison of low-flow cardiopulmonary bypass and circulatory arrest","volume":"92","author":"Wernovsky","year":"1995","journal-title":"Circulation"},{"key":"10.1016\/j.healun.2019.05.007_bib0017","doi-asserted-by":"crossref","first-page":"529","DOI":"10.1097\/PCC.0000000000000153","article-title":"Vasoactive-inotropic score is associated with outcome after infant cardiac surgery: an analysis from the Pediatric Cardiac Critical Care Consortium and Virtual PICU System Registries","volume":"15","author":"Gaies","year":"2014","journal-title":"Pediatr Crit Care Med"},{"key":"10.1016\/j.healun.2019.05.007_bib0018","doi-asserted-by":"crossref","first-page":"234","DOI":"10.1097\/PCC.0b013e3181b806fc","article-title":"Vasoactive-inotropic score as a predictor of morbidity and mortality in infants after cardiopulmonary bypass","volume":"11","author":"Gaies","year":"2010","journal-title":"Pediatr Crit Care Med"},{"key":"10.1016\/j.healun.2019.05.007_bib0019","doi-asserted-by":"crossref","first-page":"567","DOI":"10.1111\/petr.12112","article-title":"Vasoactive-inotropic score after pediatric heart transplant: a marker of adverse outcome","volume":"17","author":"Sanil","year":"2013","journal-title":"Pediatr Transplant"},{"key":"10.1016\/j.healun.2019.05.007_bib0020","doi-asserted-by":"crossref","first-page":"167","DOI":"10.1007\/s00540-018-2447-2","article-title":"Vasoactive-inotropic score as a predictor of morbidity and mortality in adults after cardiac surgery with cardiopulmonary bypass","volume":"32","author":"Yamazaki","year":"2018","journal-title":"J Anesth"},{"key":"10.1016\/j.healun.2019.05.007_bib0021","doi-asserted-by":"crossref","first-page":"682","DOI":"10.1016\/j.healun.2014.02.022","article-title":"Predictors of hospital length of stay after implantation of a left ventricular assist device: an analysis of the INTERMACS registry","volume":"33","author":"Cotts","year":"2014","journal-title":"J Heart Lung Transplant"},{"key":"10.1016\/j.healun.2019.05.007_bib0022","doi-asserted-by":"crossref","first-page":"162","DOI":"10.1097\/MAT.0000000000000035","article-title":"Outcomes and predictors of early mortality after continuous-flow left ventricular assist device implantation as a bridge to transplantation","volume":"60","author":"Sabashnikov","year":"2014","journal-title":"ASAIO J"},{"key":"10.1016\/j.healun.2019.05.007_bib0023","doi-asserted-by":"crossref","first-page":"214","DOI":"10.1161\/CIRCULATIONAHA.108.838656","article-title":"Model for end-stage liver disease score predicts left ventricular assist device operative transfusion requirements, morbidity, and mortality","volume":"121","author":"Matthews","year":"2010","journal-title":"Circulation"},{"key":"10.1016\/j.healun.2019.05.007_bib0024","doi-asserted-by":"crossref","first-page":"44","DOI":"10.1016\/j.jacc.2012.02.032","article-title":"Risk assessment for continuous flow left ventricular assist devices: does the destination therapy risk score work? An analysis of over 1,000 patients","volume":"60","author":"Teuteberg","year":"2012","journal-title":"J Am Coll Cardiol"},{"key":"10.1016\/j.healun.2019.05.007_bib0025","doi-asserted-by":"crossref","first-page":"313","DOI":"10.1016\/j.jacc.2012.09.055","article-title":"Predicting survival in patients receiving continuous flow left ventricular assist devices: the HeartMate II risk score","volume":"61","author":"Cowger","year":"2013","journal-title":"J Am Coll Cardiol"},{"key":"10.1016\/j.healun.2019.05.007_bib0026","doi-asserted-by":"crossref","first-page":"2163","DOI":"10.1016\/j.jacc.2008.03.009","article-title":"The right ventricular failure risk score a pre-operative tool for assessing the risk of right ventricular failure in left ventricular assist device candidates","volume":"51","author":"Matthews","year":"2008","journal-title":"J Am Coll Cardiol"},{"key":"10.1016\/j.healun.2019.05.007_bib0027","doi-asserted-by":"crossref","DOI":"10.1161\/JAHA.117.008377","article-title":"Determinants and outcomes of vasoplegia following left ventricular assist device implantation","volume":"7","author":"Tecson","year":"2018","journal-title":"J Am Heart Assoc"},{"key":"10.1016\/j.healun.2019.05.007_bib0028","doi-asserted-by":"crossref","first-page":"291","DOI":"10.1016\/S0022-2828(85)80130-9","article-title":"Catecholamine cardiotoxicity","volume":"17","author":"Rona","year":"1985","journal-title":"J Mol Cell Cardiol"},{"key":"10.1016\/j.healun.2019.05.007_bib0029","doi-asserted-by":"crossref","first-page":"828","DOI":"10.1093\/icvts\/ivw409","article-title":"Contemporary outcome of unplanned right ventricular assist device for severe right heart failure after continuous-flow left ventricular assist device insertion","volume":"24","author":"Yoshioka","year":"2017","journal-title":"Interact Cardiovasc Thorac Surg"},{"issue":"Suppl 9","key":"10.1016\/j.healun.2019.05.007_bib0030","first-page":"II","article-title":"A prospective randomized trial of arginine vasopressin in the treatment of vasodilatory shock after left ventricular assist device placement","volume":"96","author":"Argenziano","year":"1997","journal-title":"Circulation"},{"key":"10.1016\/j.healun.2019.05.007_bib0031","doi-asserted-by":"crossref","first-page":"919","DOI":"10.1016\/j.amjcard.2012.05.021","article-title":"Outcomes of preoperative angiotensin-converting enzyme inhibitor therapy in patients undergoing isolated coronary artery bypass grafting","volume":"110","author":"Bandeali","year":"2012","journal-title":"Am J Cardiol"},{"key":"10.1016\/j.healun.2019.05.007_bib0032","doi-asserted-by":"crossref","first-page":"1778","DOI":"10.1016\/j.jacc.2009.07.008","article-title":"Effects of angiotensin-converting enzyme inhibitor therapy on clinical outcome in patients undergoing coronary artery bypass grafting","volume":"54","author":"Miceli","year":"2009","journal-title":"J Am Coll Cardiol"},{"key":"10.1016\/j.healun.2019.05.007_bib0033","doi-asserted-by":"crossref","first-page":"1664","DOI":"10.1161\/CIRCULATIONAHA.108.814533","article-title":"Early on-cardiopulmonary bypass hypotension and other factors associated with vasoplegic syndrome","volume":"120","author":"Levin","year":"2009","journal-title":"Circulation"},{"key":"10.1016\/j.healun.2019.05.007_bib0034","doi-asserted-by":"crossref","first-page":"327","DOI":"10.1016\/j.ejcts.2003.11.032","article-title":"Risk factors and outcomes for \u2019vasoplegia syndrome\u2019 following cardiac transplantation","volume":"25","author":"Byrne","year":"2004","journal-title":"Eur J Cardiothorac Surg"},{"key":"10.1016\/j.healun.2019.05.007_bib0035","doi-asserted-by":"crossref","first-page":"258","DOI":"10.1007\/s11886-000-0077-3","article-title":"Therapeutic implications of escape from angiotensin-converting enzyme inhibition in patients with chronic heart failure","volume":"2","author":"Ennezat","year":"2000","journal-title":"Curr Cardiol Rep"},{"key":"10.1016\/j.healun.2019.05.007_bib0036","doi-asserted-by":"crossref","first-page":"588","DOI":"10.1056\/NEJMra002709","article-title":"The pathogenesis of vasodilatory shock","volume":"345","author":"Landry","year":"2001","journal-title":"N Engl J Med"}],"container-title":["The Journal of Heart and Lung Transplantation"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1053249819315116?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1053249819315116?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,11,5]],"date-time":"2025-11-05T15:13:04Z","timestamp":1762355584000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1053249819315116"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2019,9]]},"references-count":36,"journal-issue":{"issue":"9","published-print":{"date-parts":[[2019,9]]}},"alternative-id":["S1053249819315116"],"URL":"https:\/\/doi.org\/10.1016\/j.healun.2019.05.007","relation":{},"ISSN":["1053-2498"],"issn-type":[{"value":"1053-2498","type":"print"}],"subject":[],"published":{"date-parts":[[2019,9]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Prognostic value of vasoactive-inotropic score following continuous flow left ventricular assist device implantation","name":"articletitle","label":"Article Title"},{"value":"The Journal of Heart and Lung Transplantation","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.healun.2019.05.007","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2019 International Society for Heart and Lung Transplantation. All rights reserved.","name":"copyright","label":"Copyright"}]}}